Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Fertility treatments, collectively termed Assisted Reproductive Techniques (ART), are now widely available for routine clinical use. However, there is a lack of cost-effectiveness evidence for fertility treatments. This, in part, reflects challenges associated with estimating the health-related quality of life (HRQoL) impacts of infertility and subfertility.